Xeris Biopharma Holdings Inc. buy Jefferies Financial Group Inc.
Start price
03.02.25
/
50%
€3.49
Target price
03.02.26
€5.81
Performance (%)
71.35%
Price
14:25
€5.98
Summary
This prediction is currently active. With a performance of 71.35% the BUY prediction by Jefferies_Financial_ is a big success. This prediction currently runs until 03.02.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | - | - |
| iShares Core DAX® | 1.803% | 0.496% |
| iShares Nasdaq 100 | 0.429% | -0.410% |
| iShares Nikkei 225® | 0.708% | -3.799% |
| iShares S&P 500 | 0.288% | -0.218% |
Comments by Jefferies_Financial_ for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for XERS provided by MarketBeat